Buyers use HPLC data differently from analysts. An analyst asks what the chromatogram shows; a buying officer has to decide whether two quotes are comparable, whether a supplier's documentation habits are consistent, and whether a purity figure in a sales email means anything at all. The analytical explanation of the measurement lives in reading HPLC purity on a peptide COA. This page is about the purchasing decisions that sit on top of it.
A percentage without a method is not a specification
The most expensive habit in laboratory purchasing is comparing suppliers on a single number lifted out of a product page. Column chemistry, gradient, detection wavelength, and integration rules all move the reported figure. Two honest laboratories can print different percentages for the same material, so a bare percentage is not something you can rank quotes by.
Ask for the method description alongside the number. If a supplier can produce the wavelength, run conditions, and the lot the chromatogram belongs to, you have something comparable. If the number arrives with no method behind it, it should carry no weight in a supplier scoring exercise.
Compare documents, not claims
When you evaluate a supplier, request records for two or three different lots rather than a single flattering example. Look for consistency in the documentation itself: the same fields present each time, methods described the same way, dates that make sense relative to the order, and lot identifiers that match what the vials will carry.
A supplier whose records vary in structure from lot to lot is telling you something about how the files are assembled. That signal is more useful than any individual figure, and it survives the fact that you cannot audit an overseas analytical laboratory from a desk in Dubai. Comparing peptide suppliers in the UAE sets out the wider evaluation criteria.
Purity and identity are separate purchases
A purity figure describes how clean a chromatogram looks under one method. It does not establish what the main peak is. A lot can present a very high purity number and still be predominantly the wrong sequence, which is why a record carrying only purity is weaker than one carrying an identity method too. Mass spectrometry on a peptide COA explains what the identity line is doing.
For purchasing, write both requirements into your specification instead of accepting whichever field the supplier happens to publish. Otherwise you end up qualifying vendors on the metric that is easiest to produce.
What purity does not tell you about net content
Buyers often assume a purity percentage describes how much of the vial's weight is peptide. It generally does not. Synthetic peptides typically carry a counterion from purification along with residual water and solvent, and none of that appears as an impurity peak.
The consequence is a purchasing one. If your specification is written in terms of usable material, then peptide content, where a record reports it separately, is the field to work from. Two vials at the same nominal strength and headline purity can differ in net content, and the difference does not show up in the number people quote in email threads.
Build the requirement into the order, not the receiving bench
The cheapest place to enforce documentation expectations is the purchase order. State which analytical fields the record must contain, that it must correspond to the lot supplied, and what happens if it does not arrive. Receiving officers cannot create documentation that was never requested, and a specification argued about after delivery usually ends with someone accepting less than they intended.
VaultLabs publishes per-lot records where they have been uploaded, and pricing and checkout are handled in AED. The pages on lab testing standards and quality control describe what appears on published records.
Where the number stops being useful
An HPLC figure is a snapshot of one lot, on one instrument setup, on the date printed. It is not a stability statement, not a shelf-life claim, and not transferable to the next lot of the same catalogue item. Records that quietly reuse a chromatogram across lots are a documentation problem regardless of how good the number is.
Once material arrives, read the document as a whole rather than any single field. How to read a peptide COA is the field guide.
FAQ
Is a higher purity percentage always the better buy?
Not by itself. Compare the methods, confirm the record belongs to the lot you would receive, and check whether an identity method is present. A slightly lower figure on a fully described record is worth more than a higher figure with no method.
Should we run our own HPLC on incoming material?
That depends on your acceptance criteria and instrument access. Laboratories that do run incoming checks should expect their numbers to differ from the supplier's, because the methods differ. Decide in advance what size of difference triggers an investigation.
Can a supplier's purity figure be applied to a different lot?
No. Each figure belongs to the lot it was measured on. Applying it to another lot is one of the more common ways a documentation file becomes unreliable without anyone noticing.
Does strong HPLC data change how the material may be used?
No. Analytical data describes composition. Everything in the research peptides catalogue is supplied for in vitro laboratory research only.